Edwards Lifesciences Corporation (EW)

Every figure this model derived for EW, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-06-30.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 286,700,000 PaymentsToAcquirePropertyPlantAndEquipment 2026-06-30
cash 4,252,700,000 CashAndCashEquivalentsAtCarryingValue 2026-06-30
current assets 6,818,900,000 AssetsCurrent 2026-06-30
current liabilities 1,507,900,000 LiabilitiesCurrent 2026-06-30
equity 10,618,000,000 StockholdersEquity 2026-06-30
interest expense 20,400,000 InterestExpenseNonoperating 2025-12-31
ocf 1,720,300,000 NetCashProvidedByUsedInOperatingActivities 2026-06-30
revenue 6,512,300,000 RevenueFromContractWithCustomerExcludingAssessedTax 2026-06-30
sbc 168,000,000 ShareBasedCompensation 2026-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up EW on one particular measure came for.

RatioValue
cash operating margin27.37
current ratio4.52
current ratio reported4.52
dilution pct-2.25
ebit cagr-0.95
ebit yoy-1.37
ev ebit33.26
ev owner earnings38.08
ev sales7.4
fcf margin22.01
growth cv1.57
interest cover71.03
operating margin22.25
owner earnings margin19.43
revenue growth14.55
revenue growth per share17.19
roic16.44
rule of 4036.8
sbc pct revenue2.58

What to be careful about

What this model itself distrusts about EW's figures. Written by the derivation as it ran, not added afterwards.